DOI: 10.1186/s41181-017-0030-zPages: 1-4

Comparing the use of radiolabeled SSTR agonists and an SSTR antagonist in breast cancer: does the model choice influence the outcome?

1. Department of Radiology & Nuclear Medicine, Erasmus MC

Correspondence to:
Simone U. Dalm
Email: s.dalm@erasmusmc.nl

Close

Abstract

This article is freely available, click here to access the full text/PDF

  • Accepted: Sep 3, 2017
  • Online: Sep 29, 2017

Article Tools

eanm
EJNMMI Ad